DRREDDY — Dr. Reddy's Laboratories Share News
0.000.00%
Last trade - 00:00- IN₹1.02tn
- IN₹1.01tn
- IN₹337.00bn
Factbox: Global drugmakers invest billions to boost US presence
Brief: Novartis India Approves Termination Of Distribution Agreement With Dr. Reddy's Laboratories
Brief: Dr Reddy's Says Receives U.S. FDA Approval For Rituximab Biosimilar
Brief: USFDA Completes Inspection At Dr. Reddy's Fto-Sez Unit-02
Brief: Dr Reddy's Says Thai FDA Approves Nuzolvence (Zoliflodacin) - Statement
India's Dr Reddy's on track for 3rd weekly drop on semaglutide supply disruption, Q1 profit miss
Snapshot: India stocks, rupee, bonds, swaps, call at 1:00 p.m. IST
India's Cipla posts another profit decline, names insider Dinesh Jain CFO (updated)
Indian drugmaker Cipla's Q1 profit misses estimates
Indian drugmaker Dr Reddy's slips on margin, semaglutide supply woes (updated)
India Stocks: Indian shares open lower on oil surge; Dr Reddy's falls on first-quarter profit miss
Indian drugmaker Dr Reddy's slips on margin, semaglutide supply woes
Brief: Dr Reddy's Exec Says Elevated Frieght Costs Due To Middle East Issues, High Solvent Prices Impacted EBITDA This Quarter
India's Dr Reddy's warns of wider semaglutide supply impact after profit miss (updated)
Brief: Dr. Reddy's Q1 Consol Net PAT 4.44 Billion Rupees
Indian drugmaker Dr Reddy's posts quarterly profit slump
India's pharma stocks fall after Trump outlines steep tariffs on generic drug imports
India's pharma stocks fall as Trump outlines steep tariffs on generic drug imports
Preview: Analysts flag a weak quarter for Dr. Reddy's as generic Revlimid pressure persists